Predictors of Treatment Resistance and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 439 Cases in a Single Chinese Center
Author:
Affiliation:
1. Peking University First Hospital and Peking University; Beijing China
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38621/fullpdf
Reference32 articles.
1. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study;Booth;Am J Kidney Dis,2003
2. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review;Groot;Nephrol Dial Transplant,2001
3. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts;Pagnoux;Arthritis Rheum,2008
4. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis;Hogan;Ann Intern Med,2005
5. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis;Nachman;J Am Soc Nephrol,1996
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An update on risk factors for relapse in antineutrophil cytoplasmic antibody-associated vasculitis;Clinical and Experimental Immunology;2024-08-14
2. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook;Kidney Diseases;2024-08-05
3. FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα–CPT1a pathway;Rheumatology;2024-06-05
4. Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China;Arthritis Research & Therapy;2024-05-31
5. Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients;Annals of Medicine;2023-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3